临床背景下的福塞姆萨维尔耐药性:叙事性综述
Jonathan M Schapiro1, Rolf Kaiser2, Mark Krystal3
1Sheba Medical Center, Tel Aviv, Israel.
Therapeutic advances in infectious disease
|March 27, 2025
概括
福斯特姆萨维尔是一种HIV-1附着抑制剂,用于治疗经过大量治疗的成年人多药耐药性感染. 由于复杂的病毒变异性和临床环境中不可预测的反应,耐药性测试可能提供有限的益处.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 福斯特姆萨维尔是泰姆萨维尔的前药物,这是多药耐药性HIV-1的第一类gp120定向附着抑制剂.
- 泰姆萨维尔向HIV-1 gp120,通过阻断CD4结合来抑制病毒的进入.
- 由于gp120中的特定氨基酸替代,对姆萨维尔的耐药性可能会出现,尽管患病率因亚型而异.
研究的目的:
- 评估在接受Fostemsavir的强度治疗经验 (HTE) 的成年人中测试泰姆萨维尔耐药性的临床实用性.
- 了解HIV-1 gp120变异性对泰姆萨维尔敏感性和治疗反应的影响.
- 为 HTE 患者的临床管理策略提供信息,这些患者在基于 fostemsavir 的疗法上出现病毒学失败.
主要方法:
- 在HIV-1 gp120中氨基酸替代的分析与泰姆萨维尔耐药性相关.
- 临床分离物的体外敏感性对特姆萨维尔的评估.
- 从III期BRIGHTE研究的数据的审查,包括基因型和表型耐药性,病毒载量和CD4+T细胞计数.
主要成果:
- 特定的gp120多态 (例如,在位置375,426,434,475,202) 与特马维尔敏感性降低有关.
- 艾滋病毒-1 gp120的变异性导致临床分离的敏感性高度变化,挑战体外预测.
- 一些患者在BRIGHTE研究中实现了病毒再抑制和CD4+T细胞增加,尽管有证据表明temsavir敏感性降低.
结论:
- 在治疗前对泰姆萨维尔的基因型或表型耐药性测试可能在HTE个体中具有有限的预测价值.
- 病毒学失败的临床管理需要个性化的方法,考虑到除了病毒抑制之外的好处.
- 需要进一步的研究,以建立可靠的预测算法,用于复杂的HIV-1病例的 fostemsavir治疗.
相关概念视频
02:33Retroviruses
12.1K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.1K
01:10Retrovirus Life Cycles
45.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.5K
01:21Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
00:57Antibiotic Selection
52.1K
Overview
52.1K
01:23Cystic Fibrosis: Pathogenesis
170
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
170
00:36Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K